2016
Air toxics and early childhood acute lymphocytic leukemia in Texas, a population based case control study
Symanski E, Tee Lewis PG, Chen TY, Chan W, Lai D, Ma X. Air toxics and early childhood acute lymphocytic leukemia in Texas, a population based case control study. Environmental Health 2016, 15: 70. PMID: 27301866, PMCID: PMC4908700, DOI: 10.1186/s12940-016-0154-8.Peer-Reviewed Original ResearchMeSH KeywordsAdultAir PollutantsBenzeneButadienesCase-Control StudiesChild, PreschoolEnvironmental MonitoringFemaleHumansInfantInfant, NewbornMaleMaternal ExposureOdds RatioPolycyclic Aromatic HydrocarbonsPrecursor Cell Lymphoblastic Leukemia-LymphomaPregnancyPrenatal Exposure Delayed EffectsTexasYoung AdultConceptsAcute lymphocytic leukemiaCo-pollutant modelsCase-control studySingle-pollutant modelsChildhood leukemiaLymphocytic leukemiaChildhood acute lymphocytic leukemiaBirth certificatesCancer registry casesPopulation-based controlsEarly life exposureMixed effects logistic regression modelsEarly childhood risksLogistic regression modelsPotential confoundersEtiologic roleLowest quartileRegistry casesInfant characteristicsLife exposurePediatric cancerMaternal addressControl studyBirth recordsLeukemia
2013
The cost implications of prostate cancer screening in the Medicare population
Ma X, Wang R, Long JB, Ross JS, Soulos PR, Yu JB, Makarov DV, Gold HT, Gross CP. The cost implications of prostate cancer screening in the Medicare population. Cancer 2013, 120: 96-102. PMID: 24122801, PMCID: PMC3867600, DOI: 10.1002/cncr.28373.Peer-Reviewed Original ResearchConceptsProstate cancerScreening costsAnnual screening costsPopulation-based cohortProstate cancer screeningHospital referral region levelMale Medicare beneficiariesProstate-specific antigenCancer screeningLowest quartileHRR levelMedicare populationMedicare beneficiariesOlder menNational feeCancerService Medicare programCancer diagnosisMenQuartilePSACost implicationsAnnual expenditureMedicare programBiopsyThe Cost of Breast Cancer Screening in the Medicare Population
Gross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, Gold HT, Chagpar AB, Ma X. The Cost of Breast Cancer Screening in the Medicare Population. JAMA Internal Medicine 2013, 173: 220-226. PMID: 23303200, PMCID: PMC3638736, DOI: 10.1001/jamainternmed.2013.1397.Peer-Reviewed Original ResearchConceptsBreast cancer screeningCancer screeningTreatment costsBetter breast cancer outcomesEnd Results-Medicare databaseService MedicareHigh screening costsWomen ages 66Breast cancer outcomesInitial cancer treatmentHospital referral region levelWomen 75 yearsInitial treatment costsEarly-stage cancerDigital screening mammographyCancer outcomesCancer incidenceCancer stageLowest quartileAge 66Breast cancerOlder womenMedicare populationComputer-aided detectionTreatment expenditures
2009
Energy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort
Sue LY, Schairer C, Ma X, Williams C, Chang SC, Miller AB, McCarty CA, Willcox BJ, Ziegler RG. Energy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort. Cancer Epidemiology Biomarkers & Prevention 2009, 18: 2842-2850. PMID: 19843674, PMCID: PMC2783562, DOI: 10.1158/1055-9965.epi-09-0087.Peer-Reviewed Original ResearchConceptsFood frequency questionnaireOvarian Cancer Screening Trial (PLCO) cohortPostmenopausal breast cancerBreast cancerEnergy intakeTrial cohortDietary assessmentIncident breast cancerBody mass indexBreast cancer riskFirst food frequency questionnaireLower energy intakeModest positive associationMultivariate RRsFrequency questionnaireHighest quartileMass indexLowest quartilePhysical activitySimilar riskCancer riskHuman studiesAge 55CancerAnimal experiments